Shohet Stephen B. 4
4 · Amphastar Pharmaceuticals, Inc. · Filed Nov 24, 2017
Insider Transaction Report
Form 4
Shohet Stephen B.
Director
Transactions
- Exercise/Conversion
Common Stock
2017-11-22$10.77/sh+7,862$84,674→ 31,978 total - Exercise/Conversion
Stock Option (right to buy)
2017-11-22−7,862→ 23,590 totalExercise: $10.77Exp: 2017-12-15→ Common Stock (7,862 underlying) - Sale
Common Stock
2017-11-22$18.94/sh−7,862$148,895→ 24,116 total
Footnotes (3)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 25, 2017.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.81 to $19.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F3]Shares subject to the option are fully vested and immediately exercisable.